- Investing Ideas
- /
- Biotech Breakthroughs
Biotech Breakthroughs
UPDATED May 21, 2024
Companys with strong funding and high growth potential
75 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
9LB | US$39.00 | -6.7% | -36.1% | US$7.8b | US$77.35 | PS22.8x | E62.7% | n/a | Pharmaceuticals & Biotech | ||
XUPB | €3.38 | 0% | n/a | €162.1m | €9.73 | PS5.5x | E52.3% | n/a | Pharmaceuticals & Biotech | ||
6XC | US$34.78 | 0% | 627.6% | US$1.7b | US$50.41 | PB11.9x | E61.5% | n/a | Pharmaceuticals & Biotech | ||
I54 | HK$1.01 | 1.0% | -64.9% | HK$3.9b | HK$1.61 | PS5x | E100.1% | n/a | Pharmaceuticals & Biotech | ||
G1H | US$4.11 | -2.1% | 57.6% | US$237.9m | US$7.72 | PS2.8x | E48.3% | n/a | Pharmaceuticals & Biotech | ||
51KB | US$1.52 | -10.6% | -25.5% | US$210.8m | US$4.38 | PS4.1x | E60.2% | n/a | Pharmaceuticals & Biotech | ||
6HN | HK$2.58 | -12.2% | 76.7% | HK$7.3b | HK$3.18 | PS54x | E76.3% | n/a | Pharmaceuticals & Biotech | ||
XUPB | €3.58 | 4.7% | -5.3% | €184.4m | €9.05 | PS5.3x | E54.7% | n/a | Pharmaceuticals & Biotech | ||
471A | US$1.86 | 17.7% | -16.2% | US$142.9m | US$21.56 | PS228.9x | E67.3% | n/a | Pharmaceuticals & Biotech | ||
CJH | HK$2.34 | -5.6% | -39.9% | HK$8.9b | HK$3.16 | PS12.7x | E124.6% | 0% | Pharmaceuticals & Biotech | ||
9SO | JP¥0.14 | 0% | -51.7% | JP¥4.9b | n/a | PS12x | E64.7% | n/a | Pharmaceuticals & Biotech | ||
1YG | kr0.025 | 1.7% | -72.1% | kr478.4m | n/a | PS15.4x | E68.8% | n/a | Pharmaceuticals & Biotech | ||
2L9 | US$94.86 | -4.8% | 77.3% | US$6.5b | US$109.31 | PS23x | E66.3% | n/a | Pharmaceuticals & Biotech | ||
LWB | AU$0.67 | 6.4% | 0.8% | AU$1.3b | n/a | PS114.6x | E56.8% | n/a | Pharmaceuticals & Biotech | ||
1AEA | €368.00 | 0% | n/a | €19.6b | €485.51 | PS14.7x | E60.1% | n/a | Pharmaceuticals & Biotech | ||
LSW | UK£0.69 | 0.7% | 16.6% | UK£43.7m | UK£1.35 | PS1.9x | E133.0% | n/a | Pharmaceuticals & Biotech | ||
12V | US$20.40 | -1.0% | -15.7% | US$1.7b | US$27.94 | PS4.4x | E122.1% | n/a | Pharmaceuticals & Biotech | ||
PHG | €7.85 | -6.0% | -23.0% | €548.5m | €18.63 | PS2.3x | E58.4% | n/a | Pharmaceuticals & Biotech | ||
PHGN | €0.82 | -5.8% | -31.0% | €548.5m | €1.94 | PS2.3x | E58.4% | n/a | Pharmaceuticals & Biotech | ||
VTFN | kr15.72 | 0.3% | -14.2% | kr25.1b | kr19.62 | PS7.2x | E112.2% | 0.5% | Pharmaceuticals & Biotech | ||
49BA | US$156.00 | 4.7% | -29.1% | US$18.2b | US$248.85 | PS6.3x | E60.6% | n/a | Pharmaceuticals & Biotech | ||
AKP | US$23.60 | 0% | -4.8% | US$380.2m | US$28.41 | PS2.3x | E88.0% | n/a | Pharmaceuticals & Biotech | ||
IKAP | US$5.06 | 8.7% | -47.6% | US$797.5m | US$9.18 | PS4.2x | E52.0% | n/a | Pharmaceuticals & Biotech | ||
I4P | US$17.52 | -0.8% | 14.9% | US$794.7m | US$17.52 | PS2.5x | E42.4% | n/a | Pharmaceuticals & Biotech |